Senior Manager Regulatory Affairs - Digital Innovation Europe

Location: Berlin, Germany
Job Type: Full-Time
Employer: Amgen
For our innovative Tech Hub, based in the heart of Berlin, we are currently seeking a Senior Manager Regulatory Affairs - Digital Innovation Europe. The successful candidate will primarily provide device regulatory subject matter expertise in the assigned regional Tech Hubs and regulatory guidance for technologies that are of interest to Amgen.

Additional responsibilities

  • Responsible for providing the regulatory considerations and strategies for product prototype development, proof-of-concept activities, partnership options and vendor due diligence
  • Develop, implement, communicate, and maintain regional regulatory plans for TDI/DH (Technology Innovation/Digital Health) initiatives/ projects
  • Perform device determinations for TDI/DH programs as needed
  • Provide support with review of external communications with hospitals, clinics and academic innovation centers as well as contracts, terms and conditions from a regulatory perspective.
  • Support TDI/DH technology & software development (including co-development and supplier management) efforts by providing regulatory guidance
  • Deliver ongoing device education and training to TDI/DH colleagues pertaining to innovation
  • Assist in training Amgen Affiliates with respect to regulatory requirements of developing TDI/DH products
  • Facilitate communication of changes in Regulations, Standards, and Policy which are likely to impact TDI/DH activities
  • Represent the EU Tech Hub/Amgen at external events
  • Responsible for developing and maintaining an overall EU process map to bring digital products to market
  • Collaborate with Device Regulatory International personnel who perform EU based (legal manufacturer) registrations
  • Help identify responsible quality contact as needed for project specific needs as well as help identify responsible legal contact as needed

Minimum Reuirements

  • Doctorate degree and 2 years of relevant EU regulatory experience
  • or Master's degree and 4 years of relevant EU regulatory experience
  • or Bachelor's degree and 6 years of relevant EU regulatory experience

Preferred Qualifications

  • 5+ years experience in EU device regulatory matters
  • Some regulatory experience in drug regulatory matters
  • Multi-sectoral awareness/exposure a bonus
  • Regulatory Device and Design Control experience
  • Software development in the healthcare sector
  • Experience working in cross-functional matrix organization
  • Fluent in English

Apply for this job

About Amgen
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

Post your job offer now to start hiring the best digital health talent! For further information, please contact us.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...